Sampo plc
Sampo completes its share buyback programme
Sampo completes its share buyback programme
Sampo plc, stock exchange release, 3 November 2025 at 8:40 am EET
Sampo completes its share buyback programme
Sampo plc has completed its EUR 200 million share buyback programme, launched on 6 August 2025. The repurchases of shares began on 7 August 2025 and ended on 31 October 2025. During that period, Sampo repurchased 20,484,833 of its own A shares at an average price of EUR 9.76 per share. This corresponds to 0.76 per cent of all Sampo plc’s shares based on the share count prior to the start of this programme. The repurchase of own shares has reduced the company's unrestricted equity by EUR 200 million.
The purpose of the buyback programme was to return excess capital to shareholders by reducing Sampo plc’s capital, as the repurchased shares will be cancelled. Following the cancellation, the total number of Sampo shares will be 2,670,754,027 shares, of which 2,669,754,027 will be A shares and 1,000,000 B shares.
Further information on share buybacks is available at www.sampo.com/sharebuyback.
SAMPO PLC
Investor Relations and Group Communications
For further information, please contact:
Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030
Distribution:
Nasdaq Helsinki
Nasdaq Stockholm
Nasdaq Copenhagen
London Stock Exchange
The principal media
FIN-FSA
www.sampo.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Stablecon3.11.2025 15:10:00 CET | Press release
Stablecon and Events Venture Group Announce Strategic Investment and European Expansion with New EMEA Conference in Amsterdam
Genmab A/S3.11.2025 15:05:00 CET | Press release
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
Infoblox Inc.3.11.2025 15:00:00 CET | Press release
Infoblox Surpasses 200 Customers in Breakout Year for Universal DDI™ and Announces New Capabilities for Network Transformation
Evaxion3.11.2025 15:00:00 CET | Press release
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
F. Hoffmann-La Roche Ltd3.11.2025 15:00:00 CET | Press release
Roche to present new data from its broad and innovative haematology portfolio at ASH 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom